Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 151-157

  Dias, Sergio ^a   Thomas, Hilary ^b   Balkwill, Frances ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CYTOPATHOGENIC EFFECT; DRUG EFFECT; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALS; GRANZYMES; INTERFERON TYPE II; INTERLEUKIN-12; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHENOTYPE; PORE FORMING CYTOTOXIC PROTEINS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032484538     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<151::AID-IJC23>3.0.CO;2-I     Document Type: Article

References (23)

1. Berke, G., The Ctl's kiss of death, Cell. 81, 9-12 (1995).
2. BRUNDA, M.J., LUISTRO. L., HENDRZAK, J.A., FONTOULAKIS. M., GAROTTA, G. and GATELY, M.K., Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12,J, Immunother.,17, 71-77 (1995).
3. BRUNDA, M.J., LUISTRO, L., RUMENNIK, L., WRIGHT, R.B., DVOROZMAK, M., ALOGONE, A., WIGGINGINTOS, J.M., WILTROUT, R.H. HENDRZAK, J.A. and PALLERONI, A.V., Antitumor activity of interleukin 12 in preclinical models. Cancer Chemother. Pharmacol. (Suppl.), 38, S16-S21 (1996).
4. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Antitumor and antimetastatic activity of interleukin 12 against murine tumors. j. exp. Med., 178, 1223-1230 (1993).
5. BURKE, F., EAST, N., UPTON, C., PATEL., K. and BALKWILL, F., Interferon-γ induces cell cycle arrest und apoptosis in a model of ovarian cancer. Europ. J. Cancer. 33, 1114-1121 (1997).
6. BURKE, E., KNOWLES, R.G., EAST, N. and BALKWILL., F.R., The role of indolcamine 2.3-dioxygenase in the anti-tumour activity of human interterongamma in vivo. Int. J. Cancer, 60, 115-122 (1995).
7. CAR, B.D., ENG, V.M., SCHNYDER, B., LEHIR, M., SHAKHOV, A.N., WOKRLY, G., HUANG, S., AGUET, M., ANDERSON, T.D. and RYFFEL., B., Role of interferon-gumma in interleukin 12-induced pathology in mice. Amer. J. Pathol., 147, 1693-1707 (1995).
8. D'ANDKKA, A. and 12 OTHERS, Prpdiction of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclcar cells. J. exp. Med., 176, 1387-1398 (1992).
9. GAZZINELLI, R.T., Molecular and cellular basis of interleukin 12 activity in prophylaxis und therapy ugainst infectious diseases. Mol. Med. Today, 2, 258-267 (1996).
10. GUTTERMAN, J.U., Cytokine therapeutics: lessons from interferon α. PrOC. nat. Acad. Sci. (Wash.), 91, 1198-1205 (1994).
11. HANAHAN, D. and FOLKMAN, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364 (1996).
12. JACKSON, J.D., VAN, Y., BRUNDA, M.J., KELSEY L.S. and TALMADGE J.E., Interleukin-12 enhances peripheral hematopoicsis in-vivn. Blood. 85, 2371-2376 (1995).
13. MALIK, S.T.A., KNOWLES, R.G., EAST, N., LANDO, D., STAMP, G. and BAI KWILL.,.. F.R., Antitumour activity of gamma interferon in ascitic and solid tumour models of human ovarian cancer. Cancer Res., 51, 6643 -6649 (1991).
14. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GAITELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J. and LOTZE, M.T., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol, 153, 1697-1706 (1994).
15. SALCEDO, T.W., AZZONI, L., WOLF, S.F. and PERUSSIA, B., Modulation of perform and granzyme messenger RNA expression in human natural killer cells. J. Immunol. 151, 2511-2520 (1993).
16. SGADARI, C., ANGIOLILLO, A.L., CHERNEY, B.W., PIKE, S.E., FARBER, J.M., KONIARIS, L.G., VANGURI, P., BURD, P.R., SHEIKH, N., GUPTA, G., TERUYA F.J. And TOSATO, G., Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. nat. Acad. Sci. (Wash.), 93, 13791-13796 (1996a).
17. SGADARI, C., ANGIOLILLO A.L. and TOSATO, G., Inhibition of angiogenesis by interleukin-12 is mediated by the interfcron-inducihle protein 10. Blood, 87, 3877-3882 (1996b).
18. TANNENBAUM, C.S., WICKER, N., ARMSTRONG, D., TUBBS, R., FlNKE, J., BUKOWSKI, R.M. and HAMILTON, T.A., Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol, 156, 693-699 (1996).
19. THOMAS, H., HANBY, A.M., SMITH, R.A., HAGGER, P., PATEL., K., RAIKUNDALIA, B., CAMPLEJOHN, R.S. and BALKWILL, F.R., An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. Brit. J. Cancer, 73, 65-72 (1996).
20. TRINCHIERI, G., Interlcukin-12: a cytokinu produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84, 4008-4027 (1994).
21. VOEST, E.E., KENYON, B.M., O'REILLY, M.S., TRUITT, G., D'AMATO, R.J. and FOLKMAN, J., Inhibition of angiogenesis in vivo by intcrleukin 12. J. nat. Cancer lnst., 87, 581-586 (1995).
22. WIGGINTON, J.M., KLUHNS, D.B.. BACK, T.C., BRUNDA, M.J., WILTROUT, R.H. and Cox, G.W., Interleukin-12 primes macrophages for nitric-oxide production in-vivo and restores depressed nitric-oxide production by macrophages from tumor-bearing mice-implications for the antitumor-activity of interleukin-12 and/or imcrleukin-2 Cancer Res., 56, 1131-1136 (1996).
23. YOUNG, H.A. and HARDY. K.J., Role of interferon-gamma in immune cell regulation. J. Leukocyte Biol., 58, 373-381 (1995).